Universitätsklinikum Münster

Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults (2025) Breidenbach M, Bader P, Attarbaschi A, Rossig C, Meisel R, Metzler M, Subklewe M, et al. Journal article The Effect of Multi-Channel tDCS on the Directed Connectivity Patterns of a Case with Focal Epilepsy Using a Multi-Feature Machine Learning Evaluation (2025) Tsipourakis A, Antonakakis M, Kaiser F, Rampp S, Kovac S, Kellinghaus C, Möddel G, et al. Conference contribution Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial (2025) Tsianakas A, Passeron T, Magnolo N, Blume-Peytavi U, Kelly V, Day I, Serrao R, et al. Journal article Nierenersatztherapie in der Intensivmedizin: Übersicht über die neue S3-Leitlinie (2025) Mertes M, von Groote T, Willam C, Zarbock A Journal article High adherence to angiotensin-converting enzyme inhibitor in children and adolescents with Alport syndrome: objective verification using liquid chromatography-mass spectrometry (2025) Boeckhaus J, Tönshoff B, Weber LT, Haffner D, Pape L, Latta K, Fehrenbach H, et al. Journal article Corrigendum to “Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial” (2025) Poryo M, Gortner L, Bay J, Franz AR, Ehrhardt H, Klein L, Behnke J, et al. Journal article, Erratum Head-to-head comparison of TKI and CPI first-line treatment strategies in advanced renal cell carcinoma—Real-world data from the German research platform CARAT (2025) Goebell P, Bögemann M, Nusch A, Grünwald V, Müller L, von der Heyde E, Martens UM, et al. Journal article Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease. (2025) Grüter T, Gaig C, Crijnen YS, Titulaer MJ, Sabater L, Heidbreder A, Dargvainiene J, et al. Journal article Disease risk but not remission status determines transplant outcomes in AML: long-term outcomes of the ASAP trial (2025) Stelljes M, Middeke JM, Bug G, Wagner-Drouet EM, Müller LP, Schmid C, Krause S, et al. Journal article